International Collaborative Study To Establish The 1st International (WHO) Standard For Alpha-1-Antitrypsin Irish scientists based at Beaumont Hospital
A Simple Guide to Clinical Trials The Medical Research Charities Group (MRCG) is an umbrella group of medical
Monday, 24 November 2008 12:08 This clinical trial is being conducted in Beaumont Hospital by Professor McElvaney and
Researchers from the Department of Medicine at RCSI Beaumont Hospital attended the American Thoracic Society Annual Conference 2008
Researchers in the Department of Medicine at RCSI Beaumont Hospital have been awarded a prestigious European award to
Monday, 24 November 2008 12:41 Health Research Board (HRB)/Medical Research Charities Group (MRCG) Project Description: Current treatments for
Monday, 24 November 2008 12:25 Poster presentations DA Bergin, Greene CM, Taggart CC, O’Neill SJ and McElvaney NG.
We recently undertook a research project to identify the incidence of AATD in a representative sample of the
Monday, 24 November 2008 12:20 Funding Body: Alpha-1 Foundation (USA) Project Description: This clinical research study, to clarify
Alpha-1 antitrypsin (AAT) is an antiprotease produced chiefly by the liver. Alpha-1 antitrypsin deficiency (AATD) is a genetic
Alpha-1 Suite, RCSI Building, Beaumont Hospital, Dublin 9, Ireland
Charity Number CHY22304Â
Site Developed & Maintained by Ecom-Ireland
2021 © Copyright Alpha-1 Foundation Ireland. All rights reserved.